04.01.2013 Views

ANNUAL REPORT - Department of Biotechnology

ANNUAL REPORT - Department of Biotechnology

ANNUAL REPORT - Department of Biotechnology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

herbaceous species (P. amarus, P. fraternus, P.<br />

debilis, P. urinaria) are more closely related to each<br />

other than other species <strong>of</strong> the same genus. P.<br />

amarus showed most similarity with P.fraternus<br />

following P.debilis and P.urinaria.<br />

Systematic and molecular taxonomic studies have<br />

been conduced in Asiatic Vigna and Macrotyloma at<br />

NBPGR, New Delhi. So far a total <strong>of</strong> 193 samples <strong>of</strong><br />

Vigna and Macrotyloma have been collected from<br />

different national and international sources. Analysis<br />

<strong>of</strong> sequence variation in rDNA regions has been<br />

completed using PCR amplification <strong>of</strong> ITS1, ITS2,<br />

26S & 18S regions. Further work on cloning and<br />

sequencing <strong>of</strong> the amplified region is in progress. In<br />

an another study at NBPGR, 153 germplasm<br />

accessions <strong>of</strong> Solanum melongena; 25 accessions <strong>of</strong><br />

S. insanum and 6 accessions <strong>of</strong> S. incanum have<br />

been collected and herbarium specimens have also<br />

been deposited at Botanical Survey <strong>of</strong> India. AFLP<br />

analysis was done for 48 accessions comprising S.<br />

melongena, S. incanum, S. viarum, S. virginianum,<br />

S. sysibriifolium, S. gilo, S. violaceum, S.<br />

acculeatissimum, S. macrocarpon and intermediate<br />

types. The AFLP data differentiated species<br />

belonging to the egg plant complex (S. melongena,<br />

S. insanium, S. incanum). The 'intermediate'<br />

accessions occupied positions among the S.<br />

melongena, S. insanum and S. incanum accessions<br />

indicating that they might be natural hybrids <strong>of</strong> these<br />

species.<br />

Animal <strong>Biotechnology</strong><br />

R&D support was continued for the development <strong>of</strong><br />

novel animal vaccines and diagnostics,<br />

characterization <strong>of</strong> indigenous breeds, development<br />

<strong>of</strong> newer reproductive techniques, utilization <strong>of</strong><br />

animal byproducts etc. A new multicentric<br />

programme on various aspects <strong>of</strong> animal nutrition<br />

was also initiated. During this period, 36 new projects<br />

were considered for financial support and so far 26<br />

projects have been funded. 14 completed and 44<br />

ongoing projects were reviewed for their outcome<br />

and successful progress. Currently, 85 projects are<br />

under implementation. Significant achievements are<br />

as follows:<br />

Animal Health Care: Vaccines and Diagnostics :<br />

The technology <strong>of</strong> large scale production <strong>of</strong><br />

recombinant protective antigen (PA) based vaccine<br />

for anthrax was developed at JNU, New Delhi and<br />

transferred to industry. Phase I / II human clinical<br />

trials <strong>of</strong> recombinant vaccine has been<br />

successfully completed. Towards developing<br />

another anthrax vaccine, lethal factor (LF) and<br />

edema factor (EF) mutants <strong>of</strong> anthrax were<br />

constructed, expressed, purified and characterized.<br />

Novel mutants <strong>of</strong> EF and LF were found to be nontoxic<br />

in vitro which provided better protective efficacy<br />

in vivo and safe to be used as vaccine component.<br />

Efforts were made to develop DNA vaccine against<br />

rabies through a multicentric project implemented at<br />

CBT, JNU, New Delhi and IVRI, Izatnagar. The RNA<br />

from rabies virus virulent strain infected mouse brain<br />

was isolated and G gene was amplified and cloned in<br />

mammalian expression vector. The<br />

immun<strong>of</strong>luorescence and immunoperoxidase tests<br />

were standardized for detection <strong>of</strong> the expression <strong>of</strong><br />

rabies virus G gene in cell culture. DNA vaccine<br />

constructs using the glycoprotein gene <strong>of</strong> rabies virus<br />

ERA strain have been developed and their potency<br />

are being studied.<br />

Molecular analysis <strong>of</strong> Indian buffalopox virus (BPXV)<br />

isolates recovered from outbreaks in both cows and<br />

buffaloes was carried out at IVRI, Mukteshwer.<br />

Sequence analysis <strong>of</strong> structural and non structural<br />

genes <strong>of</strong> BPXV showed more than 96% sequence<br />

identity (over 96%) with vaccinia virus (VACV) at the<br />

nucleotide and amino levels. PCR and PCR-RFLP<br />

based diagnostics for BPXV were devised and<br />

evaluated successfully for their diagnostic efficacy.<br />

An attenuated BPXV vaccine was developed and<br />

experimental trials in buffalo calves confirmed its<br />

safety and protection against challenge infection.<br />

Field trial <strong>of</strong> the vaccine is underway.<br />

At GBPUAT, Pantnagar, molecular characterization<br />

<strong>of</strong> fowl adenoviruses associated with<br />

Hydropericardium syndrome (HPS) and Inclusion<br />

81 Research and Development

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!